Kimberly MacKay
2021
In 2021, Kimberly MacKay earned a total compensation of $1.6M as Sr VP General Counsel Corporate Secretary at West Pharmaceutical Services.
Compensation breakdown
| Non-Equity Incentive Plan | $476,526 |
|---|---|
| Option Awards | $274,932 |
| Salary | $430,000 |
| Stock Awards | $330,870 |
| Other | $39,908 |
| Total | $1,552,236 |
MacKay received $476.5K in non-equity incentive plan, accounting for 31% of the total pay in 2021.
MacKay also received $274.9K in option awards, $430K in salary, $330.9K in stock awards and $39.9K in other compensation.
Rankings
In 2021, Kimberly MacKay's compensation ranked 7,109th out of 12,415 executives tracked by ExecPay. In other words, MacKay earned more than 42.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,109 out of 12,415 | 43rd |
Division Manufacturing | 3,109 out of 5,505 | 44th |
Major group Rubber And Miscellaneous Plastics Products | 41 out of 59 | 31st |
Industry group Fabricated Rubber Products, Not Elsewhere | 5 out of 8 | 38th |
Source: SEC filing on April 14, 2022.
MacKay's colleagues
We found four more compensation records of executives who worked with Kimberly MacKay at West Pharmaceutical Services in 2021.
2021
Eric Green
West Pharmaceutical Services
Chief Executive Officer
2021
Bernard Birkett
West Pharmaceutical Services
Chief Financial Officer
2021
Silji Abraham
West Pharmaceutical Services
SVP & Chief Digital Transf Officer
2021
David Montecalvo
West Pharmaceutical Services